Construct validity and reliability of the Malay version of the Fagerström test for nicotine dependence (FTND): A confirmatory factor analysis

• Published in: Tobacco induced diseases Vol. 21; no. March; pp. 36 - 7
• Main Authors: Lim, Kuang Hock, Yun, Yah Xin, Cheong, Yoon Ling, Sulaiman, Norharlina, Mahadzir, Mas Eliana, Lim, Jia Hui, Hashim, Mohd Hazilas Mat, Lim, Hui Li
• Format: Journal Article
• Language: English
• Published: Greece European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 01.03.2023; European Publishing
• Subjects: confirmatory factor analysis; daily smokers; ftnd; nicotine addiction; Research Paper; nicotine addiction; confirmatory factor analysis; daily smokers; FTND
• ISSN: 1617-9625; 2070-7266; 1617-9625
• DOI: 10.18332/tid/159624

The Fagerström test for nicotine dependence (FTND) was forward-backwards translated into the Malay language (FTND-M) and administered to 152 daily smokers who sought treatment for smoking cessation in government health clinics in Selangor state, Malaysia. Using confirmatory factor analysis (CFA), four measurement models with the best relative fit were compared, one uni-dimensional model, and three different two-domain (morning and daytime smoking) models. The findings indicate that the best model of the FTND-M was a two-domain model, wherein domain one represented morning smoking (time to first cigarette of the day, smoking more in the morning, and which cigarette would you hate to give up) and domain two represented daytime smoking (cigarettes per day, difficulty refraining from smoking, and smoking when ill) which showed good model fit [χ /df=1.932, goodness of fit (GFI) of 0.967, comparative fix index (CFI) of 0.945, incremental fit index (IFI) of 0.98, Tucker-Lewis index (TLI) of 0.95 and a real mean square end of approximation (RMSEA) of 0.079, and substantial reliability >0.70]. This study indicates that the FTND-M can be used to assess these two dimensions of nicotine addiction among daily smokers in a clinical setting.